Generate Biomedicines

Generate Biomedicines is the first drug generation company, pioneering a machine learning-driven biomedical platform with the potential to produce new drugs on demand across a wide range of biological modalities — from short peptides to complex antibodies, enzymes, cytokines, and even protein compositions yet to be described. Generate Biomedicines' machine learning platform can significantly accelerate the speed of identifying and validating targets and therapeutic approaches by generating proteins that engage with target specificity, while also reducing the cost of identifying and developing clinical candidates. The company’s multimodal generative biology platform represents a fundamental shift in the field of therapeutic development, addressing key challenges in drug discovery and greatly expanding the searchable space for novel biologics.